immunovant inc glp-1 receptor agonist products as a modulator of innate immunity Bariatric Fusion GLP GLP-ONE + Receptor Activator

Fructan is a primary phytochemical in Agave plant

Insulin resistance is common in Parkinsons disease and it seems to be associated with -synuclein containing Lewy Bodies

Clinical evidence (based on the literature) on GLP-1 RAs licensed in South Asia or under regulatory approval in one or more South Asian countries is presented and based on prescription pattern and the geography of the reported patient group

Overall, the results of the PIONEER-3 study together with other recent studies suggest that the introduction of semaglutide , the first oral compound of GLP-1RA in which the subcutaneous agent has shown a positive cardiovascular benefit, is an important addition to the growing list of pharmacological options for the treatment of type-2 diabetes

Most patients might likely be focused only on weight reduction and stay oblivious to other metabolic and disease protection benefits